Summary
This Form 8-K/A filing by Biogen Idec Inc. (now Biogen Inc.) on July 24, 2012, serves as an amendment to a previous report. The primary purpose of this amendment is to correct information regarding the timing of its previously announced $500 million share repurchase program. The revised press release, furnished as an exhibit, clarifies that the share repurchase was completed after the end of the second quarter of 2012, not during the second quarter as initially stated. For investors, this correction is important for understanding the company's capital allocation activities and their precise timing. While the aggregate amount of the repurchase remains the same, the updated information provides a more accurate financial picture as of the reporting date and for the second quarter's financial condition. Investors should refer to the furnished press release for complete details on the company's operational and financial results for the three months ended June 30, 2012, with this specific timing correction.
Key Highlights
- 1Amendment to a previous 8-K filing dated July 24, 2012.
- 2Corrects the timing of a $500 million share repurchase program.
- 3The share repurchase was completed *after* the second quarter of 2012, not *during* the second quarter.
- 4The revised press release reflects this timing correction.
- 5The filing does not introduce new financial results but amends previous reporting.
- 6Focuses on clarifying a capital allocation event for investors.